US2585815A
(en)
|
1947-01-16 |
1952-02-12 |
Mclintock Duncan Menzies |
Injection syringe
|
US2564977A
(en)
|
1949-01-19 |
1951-08-21 |
Hu Quang Hsi |
Medical injecting apparatus
|
US2886497A
(en)
|
1957-04-12 |
1959-05-12 |
United States Steel Corp |
Method for determining the permeability of steel to hydrogen
|
US3232117A
(en)
|
1962-09-14 |
1966-02-01 |
Roger Gilmont Instr Inc |
Micrometer buret
|
US3416530A
(en)
|
1966-03-02 |
1968-12-17 |
Richard A. Ness |
Eyeball medication dispensing tablet
|
US3618604A
(en)
|
1969-06-09 |
1971-11-09 |
Alza Corp |
Ocular insert
|
US3641237A
(en)
|
1970-09-30 |
1972-02-08 |
Nat Patent Dev Corp |
Zero order release constant elution rate drug dosage
|
US4034756A
(en)
|
1971-01-13 |
1977-07-12 |
Alza Corporation |
Osmotically driven fluid dispenser
|
US3831583A
(en)
|
1971-03-05 |
1974-08-27 |
Univ California |
Implantable bulb for inflation of surgical implements
|
US3995635A
(en)
|
1971-09-09 |
1976-12-07 |
Alza Corporation |
Ocular insert
|
US3828777A
(en)
|
1971-11-08 |
1974-08-13 |
Alza Corp |
Microporous ocular device
|
US3845201A
(en)
|
1972-04-24 |
1974-10-29 |
S Loucas |
Solid state ophthalmic medication delivery method
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
US3914402A
(en)
|
1973-06-14 |
1975-10-21 |
Alza Corp |
Ophthalmic dosage form, for releasing medication over time
|
US4179497A
(en)
|
1973-12-17 |
1979-12-18 |
Merck & Co., Inc. |
Solid state ophthalmic medication
|
US3902495A
(en)
|
1974-01-28 |
1975-09-02 |
Cavitron Corp |
Flow control system
|
US3961628A
(en)
|
1974-04-10 |
1976-06-08 |
Alza Corporation |
Ocular drug dispensing system
|
US3949748A
(en)
|
1974-09-26 |
1976-04-13 |
Oscar Malmin |
Injection syringe having aspirating and metering capabilities
|
US3949750A
(en)
|
1974-10-07 |
1976-04-13 |
Freeman Jerre M |
Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
|
US3926188A
(en)
|
1974-11-14 |
1975-12-16 |
Alza Corp |
Laminated drug dispenser
|
US4096238A
(en)
|
1974-12-23 |
1978-06-20 |
Alza Corporation |
Method for administering drug to the gastrointestinal tract
|
US4014335A
(en)
|
1975-04-21 |
1977-03-29 |
Alza Corporation |
Ocular drug delivery device
|
NL188266C
(nl)
|
1975-07-29 |
1992-05-18 |
Merck & Co Inc |
Werkwijze ter bereiding van een oogheelkundig inplantaat.
|
US4034758A
(en)
|
1975-09-08 |
1977-07-12 |
Alza Corporation |
Osmotic therapeutic system for administering medicament
|
US3977404A
(en)
|
1975-09-08 |
1976-08-31 |
Alza Corporation |
Osmotic device having microporous reservoir
|
US4014333A
(en)
|
1975-09-22 |
1977-03-29 |
Mcintyre David J |
Instrument for aspirating and irrigating during ophthalmic surgery
|
US4077407A
(en)
|
1975-11-24 |
1978-03-07 |
Alza Corporation |
Osmotic devices having composite walls
|
US4014334A
(en)
|
1976-02-02 |
1977-03-29 |
Alza Corporation |
Laminated osmotic system for dispensing beneficial agent
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
US4111203A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system with means for improving delivery kinetics of system
|
US4111201A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for delivering selected beneficial agents having varying degrees of solubility
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
US4160452A
(en)
|
1977-04-07 |
1979-07-10 |
Alza Corporation |
Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
|
US4164559A
(en)
|
1977-09-21 |
1979-08-14 |
Cornell Research Foundation, Inc. |
Collagen drug delivery device
|
US4186184A
(en)
|
1977-12-27 |
1980-01-29 |
Alza Corporation |
Selective administration of drug with ocular therapeutic system
|
US4220153A
(en)
|
1978-05-08 |
1980-09-02 |
Pfizer Inc. |
Controlled release delivery system
|
US4220152A
(en)
|
1978-05-08 |
1980-09-02 |
Pfizer Inc. |
Delivery system
|
US4200098A
(en)
|
1978-10-23 |
1980-04-29 |
Alza Corporation |
Osmotic system with distribution zone for dispensing beneficial agent
|
US4298000A
(en)
|
1978-11-08 |
1981-11-03 |
Minnesota Mining And Manufacturing Company |
Fluid dispensing device
|
US4300557A
(en)
|
1980-01-07 |
1981-11-17 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method for treating intraocular malignancies
|
ATE9059T1
(de)
|
1980-01-28 |
1984-09-15 |
Merck & Co. Inc. |
Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension.
|
US4309776A
(en)
|
1980-05-13 |
1982-01-12 |
Ramon Berguer |
Intravascular implantation device and method of using the same
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
US4327725A
(en)
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
US4484922A
(en)
|
1981-06-25 |
1984-11-27 |
Rosenwald Peter L |
Occular device
|
US4439198A
(en)
|
1981-07-09 |
1984-03-27 |
University Of Illinois Foundation |
Biodegradable ocular insert for controlled delivery of ophthalmic medication
|
US4730013A
(en)
|
1981-10-08 |
1988-03-08 |
Merck & Co., Inc. |
Biosoluble ocular insert
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4475916A
(en)
|
1982-03-18 |
1984-10-09 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4519801A
(en)
|
1982-07-12 |
1985-05-28 |
Alza Corporation |
Osmotic device with wall comprising cellulose ether and permeability enhancer
|
US4673405A
(en)
|
1983-03-04 |
1987-06-16 |
Alza Corporation |
Osmotic system with instant drug availability
|
US4883459A
(en)
|
1983-07-29 |
1989-11-28 |
Reynaldo Calderon |
Retrograde perfusion
|
US4774091A
(en)
|
1983-10-14 |
1988-09-27 |
Sumitomo Pharmaceuticals Company, Ltd. |
Long-term sustained-release preparation
|
US4627850A
(en)
|
1983-11-02 |
1986-12-09 |
Alza Corporation |
Osmotic capsule
|
US4777049A
(en)
|
1983-12-01 |
1988-10-11 |
Alza Corporation |
Constant release system with pulsed release
|
US4634418A
(en)
|
1984-04-06 |
1987-01-06 |
Binder Perry S |
Hydrogel seton
|
US4851228A
(en)
|
1984-06-20 |
1989-07-25 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic
|
US4634427A
(en)
|
1984-09-04 |
1987-01-06 |
American Hospital Supply Company |
Implantable demand medication delivery assembly
|
US5049142A
(en)
|
1984-11-07 |
1991-09-17 |
Herrick Robert S |
Intracanalicular implant for horizontal canalicular blockade treatment of the eye
|
US5053030A
(en)
|
1984-11-07 |
1991-10-01 |
Herrick Robert S |
Intracanalicular implant for horizontal canalicular blockade treatment of the eye
|
US4712550A
(en)
|
1985-04-08 |
1987-12-15 |
Sinnett Kevin B |
Retinal tack
|
US4609374A
(en)
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
US4693886A
(en)
|
1985-04-22 |
1987-09-15 |
Alza Corporation |
Osmotic device with inert core
|
EP0201611A1
(de)
|
1985-05-10 |
1986-11-20 |
B. Braun-SSC AG |
Zwei-Kanülen-Spritze
|
CA1314481C
(en)
|
1986-12-23 |
1993-03-16 |
Marcel B. Bally |
Liposomal preparation and antibiotic
|
US4781675A
(en)
|
1985-11-27 |
1988-11-01 |
White Thomas C |
Infusion cannula
|
DE3672981D1
(de)
|
1985-11-27 |
1990-08-30 |
Thomas C White |
Gewebeimplantierbare fluessigkeitsverteileinrichtung.
|
US4959217A
(en)
|
1986-05-22 |
1990-09-25 |
Syntex (U.S.A.) Inc. |
Delayed/sustained release of macromolecules
|
US5322691A
(en)
|
1986-10-02 |
1994-06-21 |
Sohrab Darougar |
Ocular insert with anchoring protrusions
|
US5147647A
(en)
|
1986-10-02 |
1992-09-15 |
Sohrab Darougar |
Ocular insert for the fornix
|
US4863457A
(en)
|
1986-11-24 |
1989-09-05 |
Lee David A |
Drug delivery device
|
US4853229A
(en)
|
1987-10-26 |
1989-08-01 |
Alza Corporation |
Method for adminstering tiny pills
|
JP2702953B2
(ja)
|
1988-01-30 |
1998-01-26 |
オリンパス光学工業株式会社 |
薬液含浸セラミックス
|
US4865846A
(en)
|
1988-06-03 |
1989-09-12 |
Kaufman Herbert E |
Drug delivery system
|
US5174999A
(en)
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
AU4951690A
(en)
|
1988-12-30 |
1990-08-01 |
David M. Anderson |
Stabilized microporous materials and hydrogel materials
|
US5141748A
(en)
|
1989-02-17 |
1992-08-25 |
Hoffmann-La Roche, Inc. |
Implant drug delivery device
|
US5098443A
(en)
|
1989-03-23 |
1992-03-24 |
University Of Miami |
Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
|
US4979938A
(en)
|
1989-05-11 |
1990-12-25 |
Iomed, Inc. |
Method of iontophoretically treating acne, furuncles and like skin disorders
|
US5164188A
(en)
|
1989-11-22 |
1992-11-17 |
Visionex, Inc. |
Biodegradable ocular implants
|
US5171270A
(en)
|
1990-03-29 |
1992-12-15 |
Herrick Robert S |
Canalicular implant having a collapsible flared section and method
|
US5324280A
(en)
|
1990-04-02 |
1994-06-28 |
Alza Corporation |
Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
|
US5128145A
(en)
|
1990-06-13 |
1992-07-07 |
Alza Corporation |
Dosage form for Parkinson's disease, spasticity and muscle spasms
|
US5238687A
(en)
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5084021A
(en)
|
1990-11-02 |
1992-01-28 |
Baldwin Brian E |
Patient controlled infusion apparatus and method
|
US5378475A
(en)
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
AU650113B2
(en)
|
1991-04-05 |
1994-06-09 |
Eli Lilly And Company |
Sustained release capsule and formulations
|
US5334189A
(en)
|
1991-06-03 |
1994-08-02 |
Wade Stephen E |
Device for controlled diffusion of a chemical substance
|
US5282829A
(en)
|
1991-08-15 |
1994-02-01 |
United States Surgical Corporation |
Hollow body implants
|
FR2682090B1
(fr)
|
1991-10-03 |
1993-12-31 |
Holzstoff Holding Sa |
Systeme-reservoir pour diffusion prolongee d'un principe actif.
|
US5681572A
(en)
|
1991-10-18 |
1997-10-28 |
Seare, Jr.; William J. |
Porous material product and process
|
US5178635A
(en)
|
1992-05-04 |
1993-01-12 |
Allergan, Inc. |
Method for determining amount of medication in an implantable device
|
US6096756A
(en)
|
1992-09-21 |
2000-08-01 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
|
US5336175A
(en)
|
1992-10-29 |
1994-08-09 |
Mames Robert N |
Method for the treatment of retinal detachments
|
US5519030A
(en)
|
1993-10-07 |
1996-05-21 |
Senju Pharmaceutical Co., Ltd. |
Method for prophylaxis and treatment of myopia
|
US5443505A
(en)
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
CA2140053C
(en)
|
1994-02-09 |
2000-04-04 |
Joel S. Rosenblatt |
Collagen-based injectable drug delivery system and its use
|
US5770076A
(en)
|
1994-03-07 |
1998-06-23 |
The Regents Of The University Of California |
Micromachined capsules having porous membranes and bulk supports
|
US5985328A
(en)
|
1994-03-07 |
1999-11-16 |
Regents Of The University Of California |
Micromachined porous membranes with bulk support
|
US5578042A
(en)
|
1994-03-14 |
1996-11-26 |
Cumming; J. Stuart |
Ophthalmic kit and method for lens insertion
|
US5466233A
(en)
|
1994-04-25 |
1995-11-14 |
Escalon Ophthalmics, Inc. |
Tack for intraocular drug delivery and method for inserting and removing same
|
AUPM897594A0
(en)
|
1994-10-25 |
1994-11-17 |
Daratech Pty Ltd |
Controlled release container
|
AU708529B2
(en)
|
1994-11-10 |
1999-08-05 |
University Of Kentucky Research Foundation, The |
Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
|
US5725493A
(en)
|
1994-12-12 |
1998-03-10 |
Avery; Robert Logan |
Intravitreal medicine delivery
|
US5554132A
(en)
|
1995-03-30 |
1996-09-10 |
Abbott Laboratories |
Hand grip for use with syringe
|
IL113723A
(en)
|
1995-05-14 |
2002-11-10 |
Optonol Ltd |
Intraocular implant
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
US5773019A
(en)
|
1995-09-27 |
1998-06-30 |
The University Of Kentucky Research Foundation |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
|
US6641708B1
(en)
|
1996-01-31 |
2003-11-04 |
Board Of Regents, The University Of Texas System |
Method and apparatus for fractionation using conventional dielectrophoresis and field flow fractionation
|
GB2310149A
(en)
|
1996-02-15 |
1997-08-20 |
Nomix Chipman Ltd |
Spray gun
|
US20090005864A1
(en)
|
1996-03-18 |
2009-01-01 |
Eggleston Harry C |
Modular intraocular implant
|
US5951512A
(en)
|
1996-05-28 |
1999-09-14 |
Horizon Medical Products, Inc. |
Infusion port with modified drug reservoir
|
US5797898A
(en)
|
1996-07-02 |
1998-08-25 |
Massachusetts Institute Of Technology |
Microchip drug delivery devices
|
US5928662A
(en)
|
1996-07-31 |
1999-07-27 |
Phillips; Andrew F. |
Ocular drug delivery device
|
AU7533696A
(en)
|
1996-12-13 |
1998-06-18 |
Ciba-Geigy Ag |
New materials
|
DK0973499T3
(da)
|
1997-03-31 |
2003-11-17 |
Alza Corp |
Implanterbart diffusionsafgivelsessystem
|
US7160687B1
(en)
|
1997-05-29 |
2007-01-09 |
Cellomics, Inc. |
Miniaturized cell array methods and apparatus for cell-based screening
|
US5968008A
(en)
|
1997-08-04 |
1999-10-19 |
Grams; Guenter A. |
Cannula with parallel channels and sliding sheath
|
US5902598A
(en)
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
US6331523B1
(en)
|
1998-03-12 |
2001-12-18 |
Genentech, Inc. |
Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5
|
US6196993B1
(en)
|
1998-04-20 |
2001-03-06 |
Eyelab Group, Llc |
Ophthalmic insert and method for sustained release of medication to the eye
|
US20020198174A1
(en)
|
2001-05-07 |
2002-12-26 |
Allergan Sales, Inc. |
Disinfecting and solubilizing steroid compositions
|
FR2784296B1
(fr)
|
1998-09-18 |
2001-01-05 |
Imedex Biomateriaux |
Dispositif pour la formulation et la delivrance d'un melange, notamment pour l'application chirurgicale de ce melange
|
GB9822170D0
(en)
*
|
1998-10-13 |
1998-12-02 |
Danbioyst Uk Ltd |
Novel formulations of fexofenadine
|
US7973068B2
(en)
|
1998-10-20 |
2011-07-05 |
Omeros Corporation |
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
|
DE69917484T2
(de)
|
1998-12-14 |
2005-05-12 |
Tre Esse Progettazione Biomedica S.R.L. |
Kathetersystem zur durchführung einer intramyokardialen therapeutischen behandlung
|
EP2298311B1
(en)
|
1999-01-13 |
2012-05-09 |
Bayer HealthCare LLC |
w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
|
WO2000042012A1
(en)
|
1999-01-13 |
2000-07-20 |
Bayer Corporation |
φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
|
US7351834B1
(en)
|
1999-01-13 |
2008-04-01 |
Bayer Pharmaceuticals Corporation |
ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
DE19948783C2
(de)
|
1999-02-18 |
2001-06-13 |
Alcove Surfaces Gmbh |
Implantat
|
US7914442B1
(en)
|
1999-03-01 |
2011-03-29 |
Gazdzinski Robert F |
Endoscopic smart probe and method
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6472162B1
(en)
|
1999-06-04 |
2002-10-29 |
Thermogenesis Corp. |
Method for preparing thrombin for use in a biological glue
|
AU770975B2
(en)
|
1999-06-18 |
2004-03-11 |
Alcon Laboratories, Inc. |
Topical ophthalmic mast cell stabilizers for treating allergic eye diseases
|
TWI262914B
(en)
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
US7141581B2
(en)
|
1999-07-02 |
2006-11-28 |
Agouron Pharmaceuticals, Inc. |
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
|
US6551291B1
(en)
|
1999-08-04 |
2003-04-22 |
Johns Hopkins University |
Non-traumatic infusion cannula and treatment methods using same
|
US6638263B1
(en)
|
1999-10-12 |
2003-10-28 |
Durect Corporation |
Regulation of drug delivery through flow diversion
|
ATE283013T1
(de)
|
1999-10-21 |
2004-12-15 |
Alcon Inc |
Medikamentenzuführvorrichtung
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
CA2395461C
(en)
|
1999-12-22 |
2010-05-25 |
Sugen, Inc. |
Methods of modulating c-kit tyrosine kinase function with indolinone compounds
|
RU2262331C2
(ru)
|
2000-01-12 |
2005-10-20 |
Бектон, Дикинсон Энд Компани |
Шунт, имплантат, система и способ снижения внутриглазного давления, способ изготовления имплантата для роговицы (варианты)
|
US20050119737A1
(en)
|
2000-01-12 |
2005-06-02 |
Bene Eric A. |
Ocular implant and methods for making and using same
|
US20030212383A1
(en)
|
2001-01-05 |
2003-11-13 |
Dana Cote |
System and methods for reducing intraocular pressure
|
CA2399358C
(en)
|
2000-02-15 |
2006-03-21 |
Sugen, Inc. |
Pyrrole substituted 2-indolinone protein kinase inhibitors
|
DE10008826C2
(de)
|
2000-02-25 |
2002-03-14 |
Disetronic Licensing Ag |
Mikroperfusionsvorrichtung mit Sammelbehältnis
|
US7077848B1
(en)
|
2000-03-11 |
2006-07-18 |
John Hopkins University |
Sutureless occular surgical methods and instruments for use in such methods
|
WO2001068377A1
(fr)
|
2000-03-13 |
2001-09-20 |
Seiko Epson Corporation |
Procede de traitement de surface, article traite en surface et dispositif de traitement de surface
|
US7141152B2
(en)
|
2000-03-16 |
2006-11-28 |
Le Febre David A |
Analyte species separation system
|
US20040208910A1
(en)
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
ATE547080T1
(de)
|
2000-08-30 |
2012-03-15 |
Univ Johns Hopkins |
Vorrichtungen zur intraokularen arzneimittelabgabe
|
DE60131773T2
(de)
|
2000-09-06 |
2008-04-10 |
Alcon Inc. |
Beschichtungsmittel mit veränderbarer klebrigkeit für augenimplantate
|
US6303290B1
(en)
|
2000-09-13 |
2001-10-16 |
The Trustees Of The University Of Pennsylvania |
Encapsulation of biomaterials in porous glass-like matrices prepared via an aqueous colloidal sol-gel process
|
ATE430742T1
(de)
|
2000-12-21 |
2009-05-15 |
Smithkline Beecham Corp |
Pyrimidinamine als angiogenesemodulatoren
|
WO2002056863A2
(en)
|
2000-12-29 |
2002-07-25 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
DE60130928T2
(de)
|
2001-01-03 |
2008-07-17 |
Bausch & Lomb Inc. |
Vorrichtung zur verzögerten wirkstofffreisetzung mit beschichteten medikamentenkernen
|
WO2002053129A1
(en)
|
2001-01-03 |
2002-07-11 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with prefabricated permeable plugs
|
US6756058B2
(en)
|
2001-01-03 |
2004-06-29 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with multiple agents
|
JP4657577B2
(ja)
|
2001-01-09 |
2011-03-23 |
マイクロチップス・インコーポレーテッド |
眼への適用および他への適用のための可撓性マイクロチップデバイス
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US6878714B2
(en)
|
2001-01-12 |
2005-04-12 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
US6995162B2
(en)
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
US6872198B1
(en)
|
2001-01-24 |
2005-03-29 |
Arrow International, Inc. |
Double-y-shaped multi-lumen catheter with selectively attachable hubs
|
JP2004520900A
(ja)
|
2001-01-26 |
2004-07-15 |
ボシュ・アンド・ロム・インコーポレイテッド |
徐放薬剤送達装置の改良製造方法
|
US7181287B2
(en)
|
2001-02-13 |
2007-02-20 |
Second Sight Medical Products, Inc. |
Implantable drug delivery device
|
FR2821672B1
(fr)
|
2001-03-02 |
2003-05-02 |
Scp Dosagene R & D |
Moyens pour l'extraction de produits a analyser et leurs applications en diagnostic et analyse
|
US6713081B2
(en)
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
EP1404297B1
(en)
|
2001-06-12 |
2011-04-27 |
The Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
JP4426286B2
(ja)
|
2001-07-10 |
2010-03-03 |
テバ ファーマシューティカル インダストリーズ リミティド |
0次、0次−二相性、上昇型又は下降型薬物放出のための薬物送達システム
|
IL144446A0
(en)
|
2001-07-19 |
2002-05-23 |
Prochon Biotech Ltd |
Plasma protein matrices and methods for their preparation
|
EP1409065B1
(en)
|
2001-07-23 |
2007-01-17 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
AU2002319606B2
(en)
|
2001-07-23 |
2006-09-14 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
RU2311892C2
(ru)
|
2001-08-29 |
2007-12-10 |
КАРВАЛХО Рикардо А. П. ДЕ |
Имплантируемая и герметизируемая система для однонаправленной доставки терапевтических препаратов в ткани
|
US7749528B2
(en)
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
KR20040039428A
(ko)
|
2001-09-28 |
2004-05-10 |
산텐 세이야꾸 가부시키가이샤 |
약물-폴리에틸렌글리콜 결합체를 함유하는 안조직 내 주입제
|
US20030118649A1
(en)
|
2001-10-04 |
2003-06-26 |
Jinming Gao |
Drug delivery devices and methods
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
JP2005509883A
(ja)
|
2001-11-15 |
2005-04-14 |
アリックス,インコーポレーテッド |
試料チップ
|
US20080108672A1
(en)
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
CA2473355C
(en)
|
2002-01-18 |
2012-01-03 |
Michael E. Snyder |
Sustained release ophthalmological device and method of making and using the same
|
US8364229B2
(en)
|
2003-07-25 |
2013-01-29 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
MXPA04008903A
(es)
|
2002-03-11 |
2004-11-26 |
Alcon Inc |
Sistema de suministro de farmaco implantable.
|
US7074426B2
(en)
|
2002-03-27 |
2006-07-11 |
Frank Kochinke |
Methods and drug delivery systems for the treatment of orofacial diseases
|
US7968569B2
(en)
|
2002-05-17 |
2011-06-28 |
Celgene Corporation |
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
US7939094B2
(en)
|
2002-06-19 |
2011-05-10 |
Boston Scientific Scimed, Inc. |
Multiphase polymeric drug release region
|
WO2004006889A1
(en)
|
2002-07-15 |
2004-01-22 |
Alcon, Inc. |
Bioerodible film for ophthalmic drug delivery
|
US8425549B2
(en)
|
2002-07-23 |
2013-04-23 |
Reverse Medical Corporation |
Systems and methods for removing obstructive matter from body lumens and treating vascular defects
|
US20040019325A1
(en)
|
2002-07-29 |
2004-01-29 |
Medrip Ltd. |
Syringe Pump
|
US20070219632A1
(en)
|
2002-08-02 |
2007-09-20 |
David Castillejos |
Method and intra-sclera implant for treatment of glaucoma and presbyopia
|
AU2003272575B2
(en)
|
2002-09-18 |
2007-11-08 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
US7468065B2
(en)
|
2002-09-18 |
2008-12-23 |
Allergan, Inc. |
Apparatus for delivery of ocular implants
|
US20050143363A1
(en)
|
2002-09-29 |
2005-06-30 |
Innorx, Inc. |
Method for subretinal administration of therapeutics including steroids; method for localizing pharmacodynamic action at the choroid of the retina; and related methods for treatment and/or prevention of retinal diseases
|
US7794437B2
(en)
|
2003-01-24 |
2010-09-14 |
Doheny Retina Institute |
Reservoirs with subretinal cannula for subretinal drug delivery
|
WO2004073551A2
(en)
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
US7452913B2
(en)
|
2003-02-24 |
2008-11-18 |
Pharmacia & Upjohn Company |
Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
|
US20060258000A1
(en)
|
2003-02-26 |
2006-11-16 |
Allen Jared W |
Use of steady-state oxygen gradients to modulate animal cell functions
|
US20050255144A1
(en)
|
2003-04-09 |
2005-11-17 |
Directcontact Llc |
Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
|
US20050074497A1
(en)
|
2003-04-09 |
2005-04-07 |
Schultz Clyde L. |
Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
|
US7094222B1
(en)
|
2003-04-28 |
2006-08-22 |
The United States Of America As Represented By The Secretary Of Navy |
Syringe device for simultaneous infusion and withdrawal
|
CA2524271C
(en)
|
2003-05-02 |
2012-09-04 |
Surmodics, Inc. |
Controlled release bioactive agent delivery device
|
EP1671624B1
(en)
|
2003-05-02 |
2010-08-11 |
SurModics, Inc. |
Delivery device for a controlled drug release of an active agent into the posterior section of the eye
|
US7297709B2
(en)
|
2003-05-22 |
2007-11-20 |
Abbott Laboratories |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
|
CA2529048A1
(en)
|
2003-06-13 |
2005-02-24 |
Becton, Dickinson And Company |
Improved intra-dermal delivery of biologically active agents
|
US20040260380A1
(en)
|
2003-06-18 |
2004-12-23 |
D-Crown Ltd |
Devices for delivering multiple stenting structures in situ
|
WO2004112653A2
(en)
|
2003-06-18 |
2004-12-29 |
D-Crown Ltd. |
Devices and methods for delivering and forming single and multiple stenting structures in situ
|
US20040260381A1
(en)
|
2003-06-18 |
2004-12-23 |
D-Crown Ltd |
Devices and methods for forming stenting structures in situ
|
US8367410B2
(en)
|
2003-06-20 |
2013-02-05 |
Massachusetts Institute Of Technology |
Application of electrical stimulation for functional tissue engineering in vitro and in vivo
|
ZA200508654B
(en)
|
2003-07-10 |
2007-01-31 |
Alcon Inc |
Ophthalmic drug delivery device
|
FI120333B
(fi)
|
2003-08-20 |
2009-09-30 |
Bioretec Oy |
Huokoinen lääketieteellinen väline ja menetelmä sen valmistamiseksi
|
AU2004274026A1
(en)
|
2003-09-18 |
2005-03-31 |
Macusight, Inc. |
Transscleral delivery
|
US20050181018A1
(en)
|
2003-09-19 |
2005-08-18 |
Peyman Gholam A. |
Ocular drug delivery
|
AU2006225241B2
(en)
|
2003-09-24 |
2008-07-17 |
Tianda Pharmaceuticals (Australia) Pty Limited |
Medication Holder
|
NZ546730A
(en)
|
2003-09-24 |
2008-04-30 |
Medi Stream Pty Ltd |
Medication holder
|
US7615141B2
(en)
|
2003-10-03 |
2009-11-10 |
University Of Washington |
Electrochemical micromanufacturing system and method
|
US20050250737A1
(en)
|
2003-11-12 |
2005-11-10 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US7211272B2
(en)
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
BRPI0507690A
(pt)
|
2004-02-12 |
2007-07-24 |
Neovista Inc |
métodos e aparelho para a braquiterapia intra-ocular
|
US7276050B2
(en)
|
2004-03-02 |
2007-10-02 |
Alan Franklin |
Trans-scleral drug delivery method and apparatus
|
US20050256499A1
(en)
|
2004-03-03 |
2005-11-17 |
Pettis Ronald J |
Methods and devices for improving delivery of a substance to skin
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
US20060182783A1
(en)
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
US8591885B2
(en)
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US20070059336A1
(en)
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US20050244472A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US8128954B2
(en)
|
2004-06-07 |
2012-03-06 |
California Institute Of Technology |
Biodegradable drug-polymer delivery system
|
US20060110428A1
(en)
|
2004-07-02 |
2006-05-25 |
Eugene Dejuan |
Methods and devices for the treatment of ocular conditions
|
US7117870B2
(en)
|
2004-07-26 |
2006-10-10 |
Clarity Corporation |
Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
|
WO2006015385A2
(en)
|
2004-08-06 |
2006-02-09 |
Sopherion Therapeutics, Inc. |
Anti-angiogenic peptides and methods of use thereof
|
WO2006031358A2
(en)
|
2004-08-13 |
2006-03-23 |
Hyperbranch Medical Technology, Inc. |
Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses
|
WO2006023530A2
(en)
|
2004-08-16 |
2006-03-02 |
Massachusetts Institute Of Technology |
Compositions and methods for enhancing structural and functional nervous system reorganization and recovery
|
WO2006031388A2
(en)
|
2004-08-20 |
2006-03-23 |
Hyperbranch Medical Technology, Inc. |
Dentritic polymers, crosslinked gels, and their uses in orthopedic applications
|
US20060052754A1
(en)
|
2004-09-04 |
2006-03-09 |
Fields Douglas W |
Thumb trigger syringe pole
|
WO2006031532A2
(en)
|
2004-09-10 |
2006-03-23 |
Surmodics, Inc. |
Methods, devices, and coatings for controlled active agent release
|
US20080038317A1
(en)
|
2004-09-10 |
2008-02-14 |
Chin-Ming Chang |
Therapeutic Lacrimal Canalicular Inserts And Related Methods
|
AU2005292145C1
(en)
|
2004-10-01 |
2011-07-21 |
Ramscor, Inc. |
Conveniently implantable sustained release drug compositions
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
WO2006044614A2
(en)
|
2004-10-14 |
2006-04-27 |
Sopherion Therapeutics, Inc. |
Anti-angiogenic peptides and methods of use thereof
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
EP1817003B1
(en)
|
2004-10-29 |
2018-02-21 |
The Regents of The University of California |
Porous silicon microparticles for drug delivery to the eye
|
US20060129215A1
(en)
|
2004-12-09 |
2006-06-15 |
Helmus Michael N |
Medical devices having nanostructured regions for controlled tissue biocompatibility and drug delivery
|
US20060128653A1
(en)
*
|
2004-12-10 |
2006-06-15 |
Chunlin Tang |
Pharmaceutical formulation of decitabine
|
US20060154981A1
(en)
|
2005-01-12 |
2006-07-13 |
Alcon, Inc. |
Method of reducing intraocular pressure and treating glaucoma
|
WO2006082588A2
(en)
|
2005-02-07 |
2006-08-10 |
Pharmalight Inc. |
Method and device for ophthalmic administration of active pharmaceutical ingredients
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
TW200640443A
(en)
|
2005-02-23 |
2006-12-01 |
Alcon Inc |
Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
|
US20060233858A1
(en)
|
2005-03-08 |
2006-10-19 |
Allergan, Inc. |
Systems and methods providing targeted intraocular drug delivery
|
KR20070121754A
(ko)
|
2005-03-21 |
2007-12-27 |
마커사이트, 인코포레이티드 |
질환 또는 상태의 치료를 위한 약물 송달 시스템
|
US20070077270A1
(en)
|
2005-03-28 |
2007-04-05 |
Clemson University |
Delivery devices and methods for long-term, targeted delivery of therapeutic agents to the eye and ear
|
US20070066138A1
(en)
|
2005-04-05 |
2007-03-22 |
The Ohio State University Research Foundation |
Diffusion Delivery Systems and Methods of Fabrication
|
US20100168535A1
(en)
|
2006-04-12 |
2010-07-01 |
Mark Ries Robinson |
Methods and apparatuses related to blood analyte measurement system
|
US20060258994A1
(en)
|
2005-05-12 |
2006-11-16 |
Avery Robert L |
Implantable delivery device for administering pharmacological agents to an internal portion of a body
|
US20070088414A1
(en)
|
2005-05-25 |
2007-04-19 |
Campbell Robert L |
Particulate formulations for intradermal delivery of biologically active agents
|
JP2009501700A
(ja)
|
2005-06-17 |
2009-01-22 |
ダイナミス・セラピユーテイクス・インコーポレーテツド |
炎症状態の治療
|
US7893040B2
(en)
|
2005-07-22 |
2011-02-22 |
Oculis Ehf |
Cyclodextrin nanotechnology for ophthalmic drug delivery
|
US8663673B2
(en)
|
2005-07-29 |
2014-03-04 |
Surmodics, Inc. |
Devices, articles, coatings, and methods for controlled active agent release or hemocompatibility
|
WO2007021671A2
(en)
|
2005-08-10 |
2007-02-22 |
Insight Instruments, Inc. |
Tool for extracting vitreous samples from an eye
|
US20070212397A1
(en)
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
JP2009508593A
(ja)
|
2005-09-16 |
2009-03-05 |
(オーエスアイ)アイテツク・インコーポレーテツド |
眼科用シリンジ
|
US20070072933A1
(en)
|
2005-09-26 |
2007-03-29 |
Peyman Gholam A |
Delivery of an ocular agent
|
WO2007038453A2
(en)
|
2005-09-26 |
2007-04-05 |
Advanced Ocular Systems Limited |
Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation
|
US20080167600A1
(en)
|
2005-09-26 |
2008-07-10 |
Peyman Gholam A |
Device for delivery of an agent to the eye and other sites
|
US20070071756A1
(en)
|
2005-09-26 |
2007-03-29 |
Peyman Gholam A |
Delivery of an agent to ameliorate inflammation
|
US20080003219A1
(en)
|
2005-09-26 |
2008-01-03 |
Minu, L.L.C. |
Delivery of an ocular agent
|
TW200732347A
(en)
|
2005-10-06 |
2007-09-01 |
Trophogen Inc |
VEGF analogs and methods of use
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
EP1948112A4
(en)
|
2005-10-11 |
2011-04-13 |
Podaima Blake |
SMART MEDICAL COMPLIANCE PROCESS AND SYSTEM
|
WO2007047744A2
(en)
|
2005-10-14 |
2007-04-26 |
Alcon, Inc. |
Method for treating primary and secondary forms of glaucoma
|
US20080125406A1
(en)
|
2005-10-14 |
2008-05-29 |
Robin Alan L |
Method for Treating Primary and Secondary Forms of Glaucoma
|
PL2500030T5
(pl)
|
2005-11-04 |
2019-02-28 |
Genentech, Inc. |
Zastosowanie inhibitorów drogi aktywacji dopełniacza w leczeniu chorób oczu
|
MX2008006379A
(es)
|
2005-11-29 |
2009-03-03 |
Smithkline Beecham Corp |
Metodo de tratamiento.
|
JP4721425B2
(ja)
|
2005-12-01 |
2011-07-13 |
キヤノン株式会社 |
流体移動方法および流体移動装置
|
WO2007066339A1
(en)
|
2005-12-07 |
2007-06-14 |
Ramot At Tel Aviv University Ltd. |
Drug-delivering composite structures
|
US20070131610A1
(en)
|
2005-12-13 |
2007-06-14 |
General Electric Company |
Membrane-based apparatus and associated method
|
US20070131611A1
(en)
|
2005-12-13 |
2007-06-14 |
General Electric Company |
Membrane-based article and associated method
|
WO2007076448A2
(en)
*
|
2005-12-23 |
2007-07-05 |
Alcon, Inc. |
Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye
|
US20080108664A1
(en)
|
2005-12-23 |
2008-05-08 |
Liu Belle B |
Solid-state form of AMG 706 and pharmaceutical compositions thereof
|
EP3632385A1
(en)
|
2006-01-17 |
2020-04-08 |
Novartis AG |
Glaucoma treatment device
|
US9084662B2
(en)
|
2006-01-17 |
2015-07-21 |
Transcend Medical, Inc. |
Drug delivery treatment device
|
US20080216736A1
(en)
|
2006-01-19 |
2008-09-11 |
Takeda San Diego, Inc. |
Microfluidic device with diffusion between adjacent lumens
|
AU2007212696B2
(en)
|
2006-02-10 |
2011-05-19 |
Amgen Inc. |
Hydrate forms of AMG706
|
WO2007100986A2
(en)
|
2006-02-24 |
2007-09-07 |
Rosetta Inpharmatics Llc |
Extraction and diagnostic fluid devices, systems and methods of use
|
WO2007101204A1
(en)
|
2006-02-27 |
2007-09-07 |
Alcon Research, Ltd. |
Method of treating glaucoma
|
US20070212388A1
(en)
|
2006-03-08 |
2007-09-13 |
Sahajanand Medical Technologies Pvt. Ltd. |
Compositions comprising porous articles and uses in implantable medical devices
|
EP1998829B1
(en)
|
2006-03-14 |
2011-02-09 |
University Of Southern California |
Mems device for delivery of therapeutic agents
|
KR20110038144A
(ko)
|
2006-03-31 |
2011-04-13 |
큐엘티 플러그 딜리버리, 인코포레이티드 |
비루관계에 대한 약물 전달 방법, 구조, 및 조성물
|
TW200800230A
(en)
|
2006-03-31 |
2008-01-01 |
Dynamis Therapeutics Inc |
Composition and method related to fructosamine-3-kinase inhibitors
|
US7547300B2
(en)
|
2006-04-12 |
2009-06-16 |
Icu Medical, Inc. |
Vial adaptor for regulating pressure
|
US8007461B2
(en)
|
2006-04-18 |
2011-08-30 |
Pingan Huo |
Sterile drug-mixing syringe
|
US8197435B2
(en)
|
2006-05-02 |
2012-06-12 |
Emory University |
Methods and devices for drug delivery to ocular tissue using microneedle
|
WO2007131050A2
(en)
|
2006-05-02 |
2007-11-15 |
Georgia Tech Research Corporation |
Method for drug delivery to ocular tissue using microneedle
|
US7981096B2
(en)
|
2006-05-12 |
2011-07-19 |
David Castillejos |
Optic nerve head implant and medication delivery system
|
US20070270750A1
(en)
|
2006-05-17 |
2007-11-22 |
Alcon, Inc. |
Drug delivery device
|
US20080124372A1
(en)
|
2006-06-06 |
2008-05-29 |
Hossainy Syed F A |
Morphology profiles for control of agent release rates from polymer matrices
|
EP2037882B1
(en)
|
2006-06-28 |
2014-12-10 |
SurModics, Inc. |
Combination degradable and non-degradable matrices for active agent delivery
|
TW200815045A
(en)
|
2006-06-29 |
2008-04-01 |
Jazz Pharmaceuticals Inc |
Pharmaceutical compositions of ropinirole and methods of use thereof
|
WO2008009120A2
(en)
|
2006-07-19 |
2008-01-24 |
Noab Biodiscoveries Inc. |
Method and device to extract components contained in a fluid
|
CA2657380A1
(en)
|
2006-07-20 |
2008-01-24 |
Neurosystec Corporation |
Devices, systems and methods for ophthalmic drug delivery
|
US20080069854A1
(en)
|
2006-08-02 |
2008-03-20 |
Inframat Corporation |
Medical devices and methods of making and using
|
US20080097335A1
(en)
|
2006-08-04 |
2008-04-24 |
Allergan, Inc. |
Ocular implant delivery assemblies
|
JP2008054521A
(ja)
|
2006-08-29 |
2008-03-13 |
Canon Inc |
細胞培養処理装置及び細胞培養処理方法
|
WO2008033924A2
(en)
|
2006-09-12 |
2008-03-20 |
Board Of Regents Of The University Of Nebraska |
Methods and compositions for targeted delivery of therapeutic agents
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
US20080089923A1
(en)
|
2006-09-29 |
2008-04-17 |
Burkstrand Michael J |
Biodegradable ocular implants and methods for treating ocular conditions
|
TW200817039A
(en)
|
2006-10-06 |
2008-04-16 |
Dynamis Therapeutics Inc |
Compositions and methods for skin lightening
|
US9022970B2
(en)
|
2006-10-16 |
2015-05-05 |
Alcon Research, Ltd. |
Ophthalmic injection device including dosage control device
|
US8609148B2
(en)
|
2006-10-25 |
2013-12-17 |
Revalesio Corporation |
Methods of therapeutic treatment of eyes
|
US8784897B2
(en)
|
2006-10-25 |
2014-07-22 |
Revalesio Corporation |
Methods of therapeutic treatment of eyes
|
AU2007349224B2
(en)
|
2006-10-25 |
2014-04-03 |
Revalesio Corporation |
Methods of wound care and treatment
|
WO2008052145A2
(en)
|
2006-10-25 |
2008-05-02 |
Revalesio Corporation |
Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
|
US8784898B2
(en)
|
2006-10-25 |
2014-07-22 |
Revalesio Corporation |
Methods of wound care and treatment
|
US20080111282A1
(en)
|
2006-11-10 |
2008-05-15 |
Baojun Xie |
Process for Making Three Dimensional Objects From Dispersions of Polymer Colloidal Particles
|
US8506515B2
(en)
|
2006-11-10 |
2013-08-13 |
Glaukos Corporation |
Uveoscleral shunt and methods for implanting same
|
US20100286791A1
(en)
|
2006-11-21 |
2010-11-11 |
Goldsmith David S |
Integrated system for the ballistic and nonballistic infixion and retrieval of implants
|
US20090263346A1
(en)
|
2006-12-05 |
2009-10-22 |
David Taft |
Systems and methods for delivery of drugs
|
WO2008070118A1
(en)
|
2006-12-05 |
2008-06-12 |
Landec Corporation |
Drug delivery
|
WO2008073295A2
(en)
|
2006-12-07 |
2008-06-19 |
Surmodics, Inc. |
Latent stabilization of bioactive agents releasable from implantable medical articles
|
US20080147021A1
(en)
|
2006-12-15 |
2008-06-19 |
Jani Dharmendra M |
Drug delivery devices
|
WO2008076544A2
(en)
|
2006-12-18 |
2008-06-26 |
Alcon Research, Ltd. |
Devices and methods for ophthalmic drug delivery
|
JP2010514517A
(ja)
|
2006-12-26 |
2010-05-06 |
キューエルティー プラグ デリバリー,インク. |
視覚欠損の抑制のための薬物送達インプラント
|
JP5201744B2
(ja)
|
2007-01-09 |
2013-06-05 |
フォヴェア ファルマシューティカル |
眼内注射装置
|
AU2008206953A1
(en)
|
2007-01-19 |
2008-07-24 |
Cinvention Ag |
Porous, non-degradable implant made by powder molding
|
UY30883A1
(es)
|
2007-01-31 |
2008-05-31 |
Alcon Res |
Tapones punctales y metodos de liberacion de agentes terapeuticos
|
GB0702864D0
(en)
|
2007-02-14 |
2007-03-28 |
Benoist Girard Sas |
Prosthetic implant for use without bone cement
|
EP2236518B1
(en)
|
2007-03-14 |
2014-08-06 |
Alexion Cambridge Corporation |
Humaneered anti-factor B antibody
|
WO2008116165A2
(en)
|
2007-03-21 |
2008-09-25 |
Next Safety, Inc. |
Methods and systems of delivering medication via inhalation
|
US20080249501A1
(en)
|
2007-04-09 |
2008-10-09 |
Medtronic Vascular, Inc. |
Methods for Simultaneous Injection and Aspiration of Fluids During a Medical Procedure
|
KR20100014486A
(ko)
|
2007-04-30 |
2010-02-10 |
알콘 리서치, 리미티드 |
보체 인자 d의 저해제를 사용한 연령 관련 황반변성의 치료
|
US20080286338A1
(en)
|
2007-05-15 |
2008-11-20 |
Boston Foundation For Sight |
Drug delivery system with scleral lens
|
US8231892B2
(en)
|
2007-05-24 |
2012-07-31 |
Allergan, Inc. |
Biodegradable drug delivery system
|
CA2688344C
(en)
|
2007-05-29 |
2019-09-03 |
Angiochem, Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
CN101327356A
(zh)
|
2007-06-21 |
2008-12-24 |
庄臣及庄臣视力保护公司 |
用于输送活性剂的泪点塞
|
ES2493641T3
(es)
|
2007-06-28 |
2014-09-12 |
Cydex Pharmaceuticals, Inc. |
Administración nasal de soluciones acuosas de corticosteroides
|
US20090036827A1
(en)
|
2007-07-31 |
2009-02-05 |
Karl Cazzini |
Juxtascleral Drug Delivery and Ocular Implant System
|
WO2009023615A1
(en)
|
2007-08-10 |
2009-02-19 |
Trustees Of Tufts College |
Tubular silk compositions and methods of use thereof
|
KR101996336B1
(ko)
|
2007-09-07 |
2019-07-04 |
마티 테라퓨틱스 인코포레이티드 |
치료 약제의 서방성 약물 코어
|
CA2698580C
(en)
|
2007-09-07 |
2016-10-11 |
Qlt Plug Delivery, Inc. |
Lacrimal implant detection
|
EP2205192A2
(en)
|
2007-09-07 |
2010-07-14 |
QLT Plug Delivery, Inc. |
Insertion and extraction tools for lacrimal implants
|
WO2009035718A1
(en)
*
|
2007-09-10 |
2009-03-19 |
Curis, Inc. |
Tartrate salts or complexes of quinazoline based egfr inhibitors containing a zinc binding moiety
|
US8308755B2
(en)
|
2007-09-24 |
2012-11-13 |
Ethicon Endo-Surgery, Inc. |
Elliptical retractor
|
US20090081272A1
(en)
|
2007-09-24 |
2009-03-26 |
John Clarke |
Medical devices having a metal particulate composition for controlled diffusion
|
US8974809B2
(en)
|
2007-09-24 |
2015-03-10 |
Boston Scientific Scimed, Inc. |
Medical devices having a filter insert for controlled diffusion
|
US20090214601A1
(en)
|
2007-09-28 |
2009-08-27 |
Chappa Ralph A |
Porous Drug Delivery Devices and Related Methods
|
KR101511497B1
(ko)
|
2007-10-05 |
2015-04-13 |
코비디엔 엘피 |
수술 절차에 사용하기 위한 밀봉부 고정구
|
US7943782B2
(en)
|
2007-10-19 |
2011-05-17 |
Abbott Laboratories |
Crystalline chemotherapeutic
|
US7772404B2
(en)
|
2007-10-19 |
2010-08-10 |
Abbott Laboratories |
Crystalline form 2 of the chemotherapeutic N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea
|
US7960564B2
(en)
|
2007-10-19 |
2011-06-14 |
Abbott Laboratories |
Crystalline chemotherapeutic
|
US20100004189A1
(en)
|
2007-10-25 |
2010-01-07 |
Revalesio Corporation |
Compositions and methods for treating cystic fibrosis
|
WO2010062628A1
(en)
|
2008-10-27 |
2010-06-03 |
Revalesio Corporation |
Compositions and methods for treating asthma and other lung disorders
|
US20090263495A1
(en)
|
2007-10-25 |
2009-10-22 |
Revalesio Corporation |
Bacteriostatic or bacteriocidal compositions and methods
|
US10125359B2
(en)
|
2007-10-25 |
2018-11-13 |
Revalesio Corporation |
Compositions and methods for treating inflammation
|
US20100303917A1
(en)
|
2007-10-25 |
2010-12-02 |
Revalesio Corporation |
Compositions and methods for treating cystic fibrosis
|
US20100303918A1
(en)
|
2007-10-25 |
2010-12-02 |
Revalesio Corporation |
Compositions and methods for treating asthma and other lung disorders
|
US20100009008A1
(en)
|
2007-10-25 |
2010-01-14 |
Revalesio Corporation |
Bacteriostatic or bacteriocidal compositions and methods
|
US20100310665A1
(en)
|
2007-10-25 |
2010-12-09 |
Revalesio Corporation |
Bacteriostatic or bacteriocidal compositions and methods
|
US20090227018A1
(en)
|
2007-10-25 |
2009-09-10 |
Revalesio Corporation |
Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
|
US9523090B2
(en)
|
2007-10-25 |
2016-12-20 |
Revalesio Corporation |
Compositions and methods for treating inflammation
|
US20100008997A1
(en)
|
2007-10-25 |
2010-01-14 |
Revalesio Corporation |
Compositions and methods for treating asthma and other lung disorders
|
AU2008316708A1
(en)
|
2007-10-25 |
2009-04-30 |
Revalesio Corporation |
Bacteriostatic or bacteriocidal compositions and methods
|
BRPI0819175A2
(pt)
|
2007-11-05 |
2015-05-05 |
Bausch & Lomb |
Composição farmacêutica oftálmica, e, método para proporcionar disponibilidade estendida de um componente farmacêutico em um ambiente ocular de um indivíduo, e, uso de pelo menos um componente farmacêutico, pelo menos um material imiscível em água e opcionalmente um composto modificador de viscosidade
|
US8114883B2
(en)
|
2007-12-04 |
2012-02-14 |
Landec Corporation |
Polymer formulations for delivery of bioactive materials
|
EP2666510B1
(en)
|
2007-12-20 |
2017-10-18 |
University Of Southern California |
Apparatus for controlled delivery of therapeutic agents
|
US8414646B2
(en)
|
2007-12-27 |
2013-04-09 |
Forsight Labs, Llc |
Intraocular, accommodating lens and methods of use
|
US20090192493A1
(en)
|
2008-01-03 |
2009-07-30 |
University Of Southern California |
Implantable drug-delivery devices, and apparatus and methods for refilling the devices
|
WO2009089409A2
(en)
|
2008-01-10 |
2009-07-16 |
Bausch & Lomb Incorporated |
Intravitreal injection system having coaxial cannulae and use thereof
|
WO2009094466A2
(en)
|
2008-01-22 |
2009-07-30 |
University Of Florida Research Foundation, Inc. |
Contact lenses for extended release of bioactive agents containing diffusion attenuators
|
WO2009097468A2
(en)
|
2008-01-29 |
2009-08-06 |
Kliman Gilbert H |
Drug delivery devices, kits and methods therefor
|
JP2011513201A
(ja)
*
|
2008-02-28 |
2011-04-28 |
武田薬品工業株式会社 |
医薬組成物
|
US8201752B2
(en)
|
2008-03-10 |
2012-06-19 |
Vapore, Inc. |
Low energy vaporization of liquids: apparatus and methods
|
TNSN08110A1
(en)
|
2008-03-11 |
2009-07-14 |
Rekik Raouf Dr |
Drug delivery to the anterior and posterior segment of the eye from drops
|
US20090240208A1
(en)
|
2008-03-19 |
2009-09-24 |
Warsaw Orthopedic, Inc. |
Microparticle delivery syringe and needle for placing particle suspensions and removing vehicle fluid
|
WO2009117112A2
(en)
|
2008-03-21 |
2009-09-24 |
Novartis Ag |
Powder dispersion apparatus, method of making and using the apparatus, components that can be used on the apparatus and other devices, and various active agents
|
KR101674492B1
(ko)
|
2008-03-31 |
2016-11-09 |
닛토덴코 가부시키가이샤 |
침투제 전달 시스템 및 그의 사용방법
|
DK2285439T3
(en)
|
2008-04-04 |
2014-03-24 |
Nektar Therapeutics |
Aerosoliseringsanorning
|
US8801665B2
(en)
|
2008-04-10 |
2014-08-12 |
Henry Ford Health System |
Apparatus and method for controlled depth of injection into myocardial tissue
|
US20090258069A1
(en)
|
2008-04-15 |
2009-10-15 |
John Burnier |
Delivery of LFA-1 antagonists to the gastrointestinal system
|
CA2722002C
(en)
|
2008-04-30 |
2018-06-19 |
Qlt Plug Delivery, Inc. |
Composite lacrimal insert and related methods
|
WO2009134929A2
(en)
|
2008-05-01 |
2009-11-05 |
Revalesio Corporation |
Compositions and methods for treating digestive disorders
|
CN103394142B
(zh)
|
2008-05-08 |
2015-08-19 |
迷你泵有限责任公司 |
可植入药物传送装置与用于填充该装置的设备和方法
|
EP2296621A1
(en)
|
2008-05-20 |
2011-03-23 |
Yale University |
Biodegradable sustained-release polymeric microparticulates comprising a hydrophobic drug and determined for ophthalmic use
|
CA2724607A1
(en)
|
2008-05-30 |
2009-12-31 |
Fairfield Clinical Trials, Llc |
Method and composition for skin inflammation and discoloration
|
US10517839B2
(en)
|
2008-06-09 |
2019-12-31 |
Cornell University |
Mast cell inhibition in diseases of the retina and vitreous
|
US20100197512A1
(en)
|
2008-07-11 |
2010-08-05 |
Intellicyt |
Multi-Sample Particle Analyzer and Method for High Throughput Screening
|
US8821870B2
(en)
|
2008-07-18 |
2014-09-02 |
Allergan, Inc. |
Method for treating atrophic age related macular degeneration
|
EP2312993A4
(en)
|
2008-07-21 |
2015-03-11 |
Arstasis Inc |
DEVICES, METHODS AND KITS FOR FORMING TISSUE TRAYS
|
US20100023033A1
(en)
|
2008-07-25 |
2010-01-28 |
Medtronic Vescular, Inc. |
Hydrodynamic Thrombectomy Catheter
|
US20100022943A1
(en)
|
2008-07-25 |
2010-01-28 |
Medtronic Vascular, Inc. |
Hydrodynamic Thrombectomy Catheter
|
ES2438496T3
(es)
*
|
2008-08-01 |
2014-01-17 |
Ventirx Pharmaceuticals, Inc. |
Formulaciones de agonistas de receptores de tipo toll y su uso
|
WO2010021993A1
(en)
|
2008-08-19 |
2010-02-25 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
|
US8221353B2
(en)
|
2008-10-21 |
2012-07-17 |
KMG Pharma, Inc |
Intravitreal injection device and system
|
US7678078B1
(en)
|
2008-10-21 |
2010-03-16 |
KMG Pharma LLC |
Intravitreal injection device, system and method
|
WO2010062394A2
(en)
|
2008-11-26 |
2010-06-03 |
Surmodics, Inc. |
Implantable ocular drug delivery device and methods
|
DE102008054431B3
(de)
|
2008-12-09 |
2010-06-17 |
Pari Pharma Gmbh |
Aerosoltherapievorrichtung
|
US20100158980A1
(en)
|
2008-12-18 |
2010-06-24 |
Casey Kopczynski |
Drug delivery devices for delivery of therapeutic agents
|
US20100174272A1
(en)
|
2009-01-02 |
2010-07-08 |
Weiner Alan L |
In-situ refillable ophthalmic implant
|
US8545554B2
(en)
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
PL2391419T3
(pl)
|
2009-01-29 |
2019-12-31 |
Forsight Vision4, Inc. |
Dostarczanie leku do tylnego odcinka
|
WO2010093945A2
(en)
|
2009-02-13 |
2010-08-19 |
Glaukos Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
TR201908314T4
(tr)
|
2009-02-20 |
2019-06-21 |
2 Bbb Medicines B V |
Glutatyon bazlı ilaç dağıtım sistemi.
|
US8912236B2
(en)
|
2009-03-03 |
2014-12-16 |
Alcon Research, Ltd. |
Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
|
US8424367B2
(en)
|
2009-03-04 |
2013-04-23 |
University Of South Carolina |
Systems and methods for measurement of gas permeation through polymer films
|
WO2010125416A1
(en)
|
2009-04-27 |
2010-11-04 |
Raouf Rekik |
Drug delivery to the anterior and posterior segments of the eye
|
US8815292B2
(en)
|
2009-04-27 |
2014-08-26 |
Revalesio Corporation |
Compositions and methods for treating insulin resistance and diabetes mellitus
|
JP2012525396A
(ja)
|
2009-04-27 |
2012-10-22 |
レバレジオ コーポレイション |
インスリン耐性および真性糖尿病を治療するための組成物および方法
|
CA2760687A1
(en)
*
|
2009-05-01 |
2010-11-04 |
Ophthotech Corporation |
Methods for treating or preventing ophthalmological diseases
|
CN102802541A
(zh)
|
2009-05-15 |
2012-11-28 |
阿尔斯塔西斯公司 |
在组织中形成管道的装置、方法和成套用具
|
WO2010135369A1
(en)
|
2009-05-18 |
2010-11-25 |
Dose Medical Corporation |
Drug eluting ocular implant
|
ES2921527T3
(es)
|
2009-06-03 |
2022-08-29 |
Forsight Vision5 Inc |
Administración de fármaco en segmento anterior
|
WO2011008896A2
(en)
|
2009-07-14 |
2011-01-20 |
Board Of Regents, The University Of Texas System |
Therapeutic methods using controlled delivery devices having zero order kinetics
|
US20110033933A1
(en)
|
2009-07-15 |
2011-02-10 |
Morteza Gharib |
Method applying hemodynamic forcing and klf2 to initiate the growth and development of cardiac valves
|
US20110117083A1
(en)
|
2009-08-14 |
2011-05-19 |
Genentech, Inc. |
Biological markers for monitoring patient response to vegf antagonists
|
JP2013502440A
(ja)
|
2009-08-27 |
2013-01-24 |
バイオノミックス リミテッド |
黄斑変性の治療
|
WO2011028850A1
(en)
|
2009-09-01 |
2011-03-10 |
Northwestern University |
Delivery of therapeutic agents using oligonucleotide-modified nanoparticles as carriers
|
EP2480270A4
(en)
|
2009-09-21 |
2015-07-08 |
Harvard Apparatus Regenerative Technology Inc |
METHODS AND APPARATUSES FOR INTRODUCING CELLS INTO A TISSUE SITE
|
WO2011069053A1
(en)
|
2009-12-04 |
2011-06-09 |
Teva Pharmaceutical Industries Ltd. |
Process for the preparation of pazopanip hcl and crystalline forms of pazopanib hcl
|
WO2011075481A1
(en)
|
2009-12-16 |
2011-06-23 |
Allergan, Inc. |
Intracameral devices for sustained delivery
|
US20110238036A1
(en)
|
2009-12-23 |
2011-09-29 |
Psivida Us, Inc. |
Sustained release delivery devices
|
TW201201808A
(en)
|
2010-01-06 |
2012-01-16 |
Glaxo Wellcome Mfg Pte Ltd |
Treatment method
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
AR081364A1
(es)
|
2010-05-05 |
2012-08-29 |
Glaxo Wellcome Mfg Pte Ltd |
Composiciones farmaceuticas de pazopanib y metodos para su elaboracion
|
WO2012019139A1
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
EP3861969A1
(en)
|
2010-08-05 |
2021-08-11 |
ForSight Vision4, Inc. |
Injector apparatus for drug delivery
|
EP2600920A4
(en)
|
2010-08-05 |
2017-10-04 |
Forsight Vision4, Inc. |
Subconjunctival implant for posterior segment drug delivery
|
SI2600812T1
(sl)
|
2010-08-05 |
2021-12-31 |
ForSight Vision4, Inc., |
Naprava za zdravljenje očesa
|
WO2012042421A1
(en)
|
2010-09-29 |
2012-04-05 |
Pfizer Inc. |
Method of treating abnormal cell growth
|
CN103458902B
(zh)
*
|
2010-10-01 |
2017-11-07 |
帆德制药股份有限公司 |
Tlr激动剂和联合治疗的治疗应用
|
WO2012065006A2
(en)
|
2010-11-11 |
2012-05-18 |
Forsight Vision4, Inc. |
Methods and apparatus to determine porous structures for drug delivery
|
CA2818612C
(en)
|
2010-11-19 |
2020-12-29 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
WO2012103060A1
(en)
|
2011-01-27 |
2012-08-02 |
Glaxo Wellcome Manufacturing Pte Ltd |
Method of administration and treatment
|
EP4249059A3
(en)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
AU2012302051B2
(en)
*
|
2011-08-30 |
2017-04-27 |
Astex Pharmaceuticals, Inc. |
Decitabine derivative formulations
|
SI2755600T1
(sl)
|
2011-09-16 |
2021-08-31 |
Forsight Vision4, Inc. |
Naprava za izmenjavo tekočine
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
ES2828656T3
(es)
|
2012-04-04 |
2021-05-27 |
Polaris Group |
Composición que comprende arginina desiminasa pegilada
|
US10251778B2
(en)
|
2012-08-06 |
2019-04-09 |
Baylor College Of Medicine |
Therapeutics dispensing device and methods of making same
|
BR112015009453A2
(pt)
*
|
2012-10-26 |
2017-07-04 |
Lupin Ltd |
composição farmacêutica estável de peg-interferona alfa-2b
|
AU2014236455B2
(en)
*
|
2013-03-14 |
2018-07-12 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
EP4302736A3
(en)
|
2013-03-28 |
2024-04-03 |
ForSight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
US20160302965A1
(en)
|
2013-12-06 |
2016-10-20 |
Forsight Vision4, Inc. |
Implantable therapeutic devices
|
US10258503B2
(en)
|
2014-07-15 |
2019-04-16 |
Forsight Vision4, Inc. |
Ocular implant delivery device and method
|
MY182793A
(en)
|
2014-08-08 |
2021-02-05 |
Forsight Vision4 Inc |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
US10500091B2
(en)
|
2014-11-10 |
2019-12-10 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and methods of use
|